Author

N. Kedei

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:imaging· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

A. L. Wink· 2 shared D. A. Wink· 2 shared D. Butcher· 2 shared D. W. McVicar· 2 shared E. F. Edmondson· 2 shared M. Pore· 2 shared S. Ambs· 2 shared S. J. Lockett· 2 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. L. Wink

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast Cancer

L. A. Ridnourl, W. F. Heinz, R. Y. Cheng, A. L. Wink, N. Kedei, M. Pore, F. Imtiaz, E. L. Femino, A. L. Gonzalez, L. Coutinho, D. Butcher, E. F. Edmondson, C. Rangel, R. J. Kinders, S. Lipkowitz, , D. A. Wink

This study identifies NOS2 and COX2 as key spatial targets in ER- breast cancer that influence immune phenotypes and clinical outcomes through spatial analysis of tumor microenvironments.

bioRxiv · Dec 21, 2023 · PreprintCancer Biology

MAIT cells have a negative impact on glioblastoma

S. keretsu, T. Hana, A. Lee, N. Kedei, N. Malik, H. Kim, J. Spurgeon, G. Khayrullina, B. Ruf, A. Hara, M. Coombs, M. Watowich, M. Watanabe, A. Hari, M. K. B. Ford, , M. Terabe

The paper identifies MAIT cells as immunosuppressive in glioblastoma, correlating their presence with poor patient survival and immune suppressive gene upregulation.

bioRxiv · Jul 17, 2022 · PreprintImmunology

NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8+ T Cell Spatial Orientation and Density

V. Somasundaram, L. A. Ridnour, R. Y. S. Cheng, A. J. Walke, N. Kedei, D. D. Bhattacharyya, A. L. Wink, E. F. Edmondson, D. Butcher, A. Warner, T. H. Dorsey, D. A. Scheiblin, W. Heinz, R. J. Bryant, R. Kinders, , D. A. Wink

This paper shows that blocking NOS2 and COX2 reduces TNBC tumor growth and improves CD8+ T cell infiltration and spatial distribution in tumors.

bioRxiv · Jun 3, 2022 · PreprintCancer Biology